Daniel Pipeleers

Daniel Pipeleers, M.D., Ph.D. is the director of the Diabetes Research Center at the Free University of Brussels. Since 2002, he has been the director of the The Center for Beta Cell Therapy in Diabetes. He founded two networks for clinical translation, the Belgian Diabetes Registry with associated Diabetes Biobank and the international Beta Cell Therapy Consortium, supported by grants from the European Commission and JDRF. Since 1990, he has been the director of the VUB-Diabetes Research Center, where expertise in beta cell biology, pathology, and therapy guides strategies and trials for early diagnosis, prevention, and treatment of type 1 diabetes. Since 1980, he has been a professor at Vrije Universiteit Brussel-VUB and since 1987, a consultant at University Hospital, Brussels. Between 1971 and 1980, he was an investigator at the Belgian Research Foundation and Harkness Fellow Commonwealth Foundation at Université Libre de Bruxelles, Washington University St Louis, Queen Elisabeth Foundation Brussels. Dr. Pipeleers is an Honorary Doctor at Uppsala University, Sweden, member of the Belgian Royal Academy of Medicine, recipient of twelve international and national awards in medical sciences. He has served as a board member and advisor in academic, clinical, and governmental institutions in scientific and bioindustrial organizations.